Related Experiment Video
Updated: Jan 30, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Thrombotic complications in adult patients with severe single coagulation factor or platelet defects - an overview
Hanne Skaadel1, Øystein Bruserud1,2
1a Section for Hematology, Department of Clinical Science , University of Bergen , Bergen , Norway.
Introduction:
Even though thrombotic events are rare in patients with coagulation deficiencies, several cases of both arterial and venous thromboses have been reported in patients with single coagulation factor defects and platelet defects. Thromboses have been described both in hemophilia A and B, von Willebrand disease as well as in many other rare congenital coagulation factor and platelet defects. Thromboses may also occur in patients with acquired hemophilia and in patients with severe thrombocytopenia due to hematological malignancies or intensive chemotherapy. Areas covered: We searched in the PubMed database to identify scientific publications describing patients with bleeding disorders and thromboses and published suggestions/guidelines for the treatment of thromboses in such patients. Expert commentary: The article gives a review of published case reports/studies of thromboses in these patients. Thromboses are rare in all these diseases. There is generally a lack controlled clinical studies for the use of anticoagulation therapy in such patients, and the article gives an overview of published suggestions and expert opinions based on the experience at large centers for treatment of thromboses in patients with congenital coagulation defects, acquired hemophilia and severe thrombocytopenia.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Hemodialysis II: Procedure and Complications

